An Update on Catheter-Based Renal Denervation for the Treatment of Hypertension View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2021-08-05

AUTHORS

Sterling A. Wheaten, Jiandong Zhang, George A. Stouffer

ABSTRACT

Purpose of ReviewThe use of catheter-based renal denervation (RD) for the treatment of hypertension showed promise in early proof-of-concept trials; however, enthusiasm to pursue clinical trials outpaced efforts to understand underlying fundamental principles. The Symplicity HTN-3 trial was a randomized, sham-controlled study that found that the effect of RD on blood pressure in patients with resistant hypertension was no different than seen in the control group. Retrospective analyses showed that the therapeutic failure more likely resulted from suboptimal first-generation technology and poor clinical trial design rather than a failure of concept. This led to the development of new catheters which deliver a more consistent ablation to renal nerves. The most recent studies which utilize these new catheters have demonstrated a consistent reduction in blood pressure, and interest in the field has been renewed.Recent FindingsIn the aftermath of early clinical trials, a reevaluation of the field of RD resulted in recommendations for improved study design, enhanced procedural techniques, and newly developed catheter technologies. These changes have been incorporated into contemporary studies, which have provided consistent evidence that catheter-based RD can cause a significant reduction in blood pressure in patients with hypertension.SummaryRecent developments in the field of RD have lent credence to the notion that a procedure-based approach to lower blood pressure may augment current treatment strategies for hypertension. Future research will help to better define its clinical role and utility. More... »

PAGES

19

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s12170-021-00682-8

DOI

http://dx.doi.org/10.1007/s12170-021-00682-8

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1140215697


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1102", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Cardiorespiratory Medicine and Haematology", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Division of Cardiology and the McAllister Heart Institute, University of North Carolina, 27599-7075, Chapel Hill, NC, USA", 
          "id": "http://www.grid.ac/institutes/grid.410711.2", 
          "name": [
            "Division of Cardiology and the McAllister Heart Institute, University of North Carolina, 27599-7075, Chapel Hill, NC, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Wheaten", 
        "givenName": "Sterling A.", 
        "id": "sg:person.0707674473.57", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0707674473.57"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Division of Cardiology and the McAllister Heart Institute, University of North Carolina, 27599-7075, Chapel Hill, NC, USA", 
          "id": "http://www.grid.ac/institutes/grid.410711.2", 
          "name": [
            "Division of Cardiology and the McAllister Heart Institute, University of North Carolina, 27599-7075, Chapel Hill, NC, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Zhang", 
        "givenName": "Jiandong", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Division of Cardiology and the McAllister Heart Institute, University of North Carolina, 27599-7075, Chapel Hill, NC, USA", 
          "id": "http://www.grid.ac/institutes/grid.410711.2", 
          "name": [
            "Division of Cardiology and the McAllister Heart Institute, University of North Carolina, 27599-7075, Chapel Hill, NC, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Stouffer", 
        "givenName": "George A.", 
        "id": "sg:person.01135215515.04", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01135215515.04"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/s00392-020-01595-z", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1124679982", 
          "https://doi.org/10.1007/s00392-020-01595-z"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2021-08-05", 
    "datePublishedReg": "2021-08-05", 
    "description": "Purpose of ReviewThe use of catheter-based renal denervation (RD) for the treatment of hypertension showed promise in early proof-of-concept trials; however, enthusiasm to pursue clinical trials outpaced efforts to understand underlying fundamental principles. The Symplicity HTN-3 trial was a randomized, sham-controlled study that found that the effect of RD on blood pressure in patients with resistant hypertension was no different than seen in the control group. Retrospective analyses showed that the therapeutic failure more likely resulted from suboptimal first-generation technology and poor clinical trial design rather than a failure of concept. This led to the development of new catheters which deliver a more consistent ablation to renal nerves. The most recent studies which utilize these new catheters have demonstrated a consistent reduction in blood pressure, and interest in the field has been renewed.Recent FindingsIn the aftermath of early clinical trials, a reevaluation of the field of RD resulted in recommendations for improved study design, enhanced procedural techniques, and newly developed catheter technologies. These changes have been incorporated into contemporary studies, which have provided consistent evidence that catheter-based RD can cause a significant reduction in blood pressure in patients with hypertension.SummaryRecent developments in the field of RD have lent credence to the notion that a procedure-based approach to lower blood pressure may augment current treatment strategies for hypertension. Future research will help to better define its clinical role and utility.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s12170-021-00682-8", 
    "inLanguage": "en", 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1039476", 
        "issn": [
          "1932-9520", 
          "1932-9563"
        ], 
        "name": "Current Cardiovascular Risk Reports", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "10", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "15"
      }
    ], 
    "keywords": [
      "catheter-based renal denervation", 
      "renal denervation", 
      "treatment of hypertension", 
      "blood pressure", 
      "clinical trials", 
      "new catheter", 
      "Symplicity HTN-3 trial", 
      "effect of RDN", 
      "lower blood pressure", 
      "sham-controlled study", 
      "current treatment strategies", 
      "early clinical trials", 
      "poor clinical trial design", 
      "clinical trial design", 
      "improved study design", 
      "failure of concept", 
      "renal nerves", 
      "resistant hypertension", 
      "therapeutic failure", 
      "treatment strategies", 
      "retrospective analysis", 
      "hypertension", 
      "clinical role", 
      "catheter technology", 
      "trial design", 
      "concept trial", 
      "control group", 
      "ReviewThe use", 
      "Recent FindingsIn", 
      "SummaryRecent developments", 
      "study design", 
      "procedural techniques", 
      "catheter", 
      "trials", 
      "denervation", 
      "patients", 
      "significant reduction", 
      "consistent reduction", 
      "consistent evidence", 
      "Recent studies", 
      "treatment", 
      "consistent ablation", 
      "failure", 
      "nerve", 
      "study", 
      "FindingsIn", 
      "pressure", 
      "ablation", 
      "procedure-based approach", 
      "future research", 
      "reduction", 
      "early proof", 
      "contemporary studies", 
      "group", 
      "evidence", 
      "reevaluation", 
      "recommendations", 
      "development", 
      "role", 
      "update", 
      "effect", 
      "utility", 
      "changes", 
      "use", 
      "promise", 
      "purpose", 
      "strategies", 
      "analysis", 
      "credence", 
      "efforts", 
      "research", 
      "technique", 
      "design", 
      "interest", 
      "approach", 
      "fundamental principles", 
      "proof", 
      "first generation technology", 
      "field", 
      "principles", 
      "aftermath", 
      "technology", 
      "concept", 
      "notion"
    ], 
    "name": "An Update on Catheter-Based Renal Denervation for the Treatment of Hypertension", 
    "pagination": "19", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1140215697"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s12170-021-00682-8"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s12170-021-00682-8", 
      "https://app.dimensions.ai/details/publication/pub.1140215697"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-05-10T10:31", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220509/entities/gbq_results/article/article_904.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s12170-021-00682-8"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s12170-021-00682-8'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s12170-021-00682-8'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s12170-021-00682-8'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s12170-021-00682-8'


 

This table displays all metadata directly associated to this object as RDF triples.

159 TRIPLES      22 PREDICATES      110 URIs      101 LITERALS      6 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s12170-021-00682-8 schema:about anzsrc-for:11
2 anzsrc-for:1102
3 schema:author N9d81390c113e4ab8aca981e0b78c181b
4 schema:citation sg:pub.10.1007/s00392-020-01595-z
5 schema:datePublished 2021-08-05
6 schema:datePublishedReg 2021-08-05
7 schema:description Purpose of ReviewThe use of catheter-based renal denervation (RD) for the treatment of hypertension showed promise in early proof-of-concept trials; however, enthusiasm to pursue clinical trials outpaced efforts to understand underlying fundamental principles. The Symplicity HTN-3 trial was a randomized, sham-controlled study that found that the effect of RD on blood pressure in patients with resistant hypertension was no different than seen in the control group. Retrospective analyses showed that the therapeutic failure more likely resulted from suboptimal first-generation technology and poor clinical trial design rather than a failure of concept. This led to the development of new catheters which deliver a more consistent ablation to renal nerves. The most recent studies which utilize these new catheters have demonstrated a consistent reduction in blood pressure, and interest in the field has been renewed.Recent FindingsIn the aftermath of early clinical trials, a reevaluation of the field of RD resulted in recommendations for improved study design, enhanced procedural techniques, and newly developed catheter technologies. These changes have been incorporated into contemporary studies, which have provided consistent evidence that catheter-based RD can cause a significant reduction in blood pressure in patients with hypertension.SummaryRecent developments in the field of RD have lent credence to the notion that a procedure-based approach to lower blood pressure may augment current treatment strategies for hypertension. Future research will help to better define its clinical role and utility.
8 schema:genre article
9 schema:inLanguage en
10 schema:isAccessibleForFree false
11 schema:isPartOf N8c060b90ac6342cca00090a4c583899e
12 N93f09b921a414808b1311b38e8b9f606
13 sg:journal.1039476
14 schema:keywords FindingsIn
15 Recent FindingsIn
16 Recent studies
17 ReviewThe use
18 SummaryRecent developments
19 Symplicity HTN-3 trial
20 ablation
21 aftermath
22 analysis
23 approach
24 blood pressure
25 catheter
26 catheter technology
27 catheter-based renal denervation
28 changes
29 clinical role
30 clinical trial design
31 clinical trials
32 concept
33 concept trial
34 consistent ablation
35 consistent evidence
36 consistent reduction
37 contemporary studies
38 control group
39 credence
40 current treatment strategies
41 denervation
42 design
43 development
44 early clinical trials
45 early proof
46 effect
47 effect of RDN
48 efforts
49 evidence
50 failure
51 failure of concept
52 field
53 first generation technology
54 fundamental principles
55 future research
56 group
57 hypertension
58 improved study design
59 interest
60 lower blood pressure
61 nerve
62 new catheter
63 notion
64 patients
65 poor clinical trial design
66 pressure
67 principles
68 procedural techniques
69 procedure-based approach
70 promise
71 proof
72 purpose
73 recommendations
74 reduction
75 reevaluation
76 renal denervation
77 renal nerves
78 research
79 resistant hypertension
80 retrospective analysis
81 role
82 sham-controlled study
83 significant reduction
84 strategies
85 study
86 study design
87 technique
88 technology
89 therapeutic failure
90 treatment
91 treatment of hypertension
92 treatment strategies
93 trial design
94 trials
95 update
96 use
97 utility
98 schema:name An Update on Catheter-Based Renal Denervation for the Treatment of Hypertension
99 schema:pagination 19
100 schema:productId N61238f38b7a84b4eb387cf5612f07b91
101 Nc99b1483fc434757be0f67845e73407f
102 schema:sameAs https://app.dimensions.ai/details/publication/pub.1140215697
103 https://doi.org/10.1007/s12170-021-00682-8
104 schema:sdDatePublished 2022-05-10T10:31
105 schema:sdLicense https://scigraph.springernature.com/explorer/license/
106 schema:sdPublisher N22ab179812434e219939742110311454
107 schema:url https://doi.org/10.1007/s12170-021-00682-8
108 sgo:license sg:explorer/license/
109 sgo:sdDataset articles
110 rdf:type schema:ScholarlyArticle
111 N22ab179812434e219939742110311454 schema:name Springer Nature - SN SciGraph project
112 rdf:type schema:Organization
113 N2fa44eb2032a48c683ab41dd0671d9f1 schema:affiliation grid-institutes:grid.410711.2
114 schema:familyName Zhang
115 schema:givenName Jiandong
116 rdf:type schema:Person
117 N37c3d23f6d30470a907fbe474b542581 rdf:first sg:person.01135215515.04
118 rdf:rest rdf:nil
119 N5a346ce4ce844f5bb617d3add88df2ab rdf:first N2fa44eb2032a48c683ab41dd0671d9f1
120 rdf:rest N37c3d23f6d30470a907fbe474b542581
121 N61238f38b7a84b4eb387cf5612f07b91 schema:name dimensions_id
122 schema:value pub.1140215697
123 rdf:type schema:PropertyValue
124 N8c060b90ac6342cca00090a4c583899e schema:issueNumber 10
125 rdf:type schema:PublicationIssue
126 N93f09b921a414808b1311b38e8b9f606 schema:volumeNumber 15
127 rdf:type schema:PublicationVolume
128 N9d81390c113e4ab8aca981e0b78c181b rdf:first sg:person.0707674473.57
129 rdf:rest N5a346ce4ce844f5bb617d3add88df2ab
130 Nc99b1483fc434757be0f67845e73407f schema:name doi
131 schema:value 10.1007/s12170-021-00682-8
132 rdf:type schema:PropertyValue
133 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
134 schema:name Medical and Health Sciences
135 rdf:type schema:DefinedTerm
136 anzsrc-for:1102 schema:inDefinedTermSet anzsrc-for:
137 schema:name Cardiorespiratory Medicine and Haematology
138 rdf:type schema:DefinedTerm
139 sg:journal.1039476 schema:issn 1932-9520
140 1932-9563
141 schema:name Current Cardiovascular Risk Reports
142 schema:publisher Springer Nature
143 rdf:type schema:Periodical
144 sg:person.01135215515.04 schema:affiliation grid-institutes:grid.410711.2
145 schema:familyName Stouffer
146 schema:givenName George A.
147 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01135215515.04
148 rdf:type schema:Person
149 sg:person.0707674473.57 schema:affiliation grid-institutes:grid.410711.2
150 schema:familyName Wheaten
151 schema:givenName Sterling A.
152 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0707674473.57
153 rdf:type schema:Person
154 sg:pub.10.1007/s00392-020-01595-z schema:sameAs https://app.dimensions.ai/details/publication/pub.1124679982
155 https://doi.org/10.1007/s00392-020-01595-z
156 rdf:type schema:CreativeWork
157 grid-institutes:grid.410711.2 schema:alternateName Division of Cardiology and the McAllister Heart Institute, University of North Carolina, 27599-7075, Chapel Hill, NC, USA
158 schema:name Division of Cardiology and the McAllister Heart Institute, University of North Carolina, 27599-7075, Chapel Hill, NC, USA
159 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...